US Patent 10828365 Treatment of asthma with anti-TSLP antibody
Patent 10828365 was granted and assigned to Amgen on November, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10828365 Treatment of asthma with anti-TSLP antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.